These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 18645180

  • 1. Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study.
    McCormick AA, Reddy S, Reinl SJ, Cameron TI, Czerwinkski DK, Vojdani F, Hanley KM, Garger SJ, White EL, Novak J, Barrett J, Holtz RB, Tusé D, Levy R.
    Proc Natl Acad Sci U S A; 2008 Jul 22; 105(29):10131-6. PubMed ID: 18645180
    [Abstract] [Full Text] [Related]

  • 2. Recombinant, tumour-derived idiotype vaccination for indolent B cell non-Hodgkin's lymphomas: a focus on FavId.
    Hurvitz SA, Timmerman JM.
    Expert Opin Biol Ther; 2005 Jun 22; 5(6):841-52. PubMed ID: 15952914
    [Abstract] [Full Text] [Related]

  • 3. A phase 2 trial of immunotherapy with mitumprotimut-T (Id-KLH) and GM-CSF following rituximab in follicular B-cell lymphoma.
    Koç ON, Redfern C, Wiernik PH, Rosenfelt F, Winter JN, Carter WD, Gold DP, Stewart ME, Ghalie RG, Bender JF.
    J Immunother; 2010 Jun 22; 33(2):178-84. PubMed ID: 20145546
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
    Timmerman JM, Singh G, Hermanson G, Hobart P, Czerwinski DK, Taidi B, Rajapaksa R, Caspar CB, Van Beckhoven A, Levy R.
    Cancer Res; 2002 Oct 15; 62(20):5845-52. PubMed ID: 12384547
    [Abstract] [Full Text] [Related]

  • 5. Cloning of idiotype immunoglobulin genes in B cell lymphomas by anchored PCR and production of individual recombinant idiotype vaccines in Escherichia coli.
    Bertinetti C, Simon F, Zirlik K, Heining-Mikesch K, Pfeifer D, Osterroth F, Rosenthal FM, Veelken H.
    Eur J Haematol; 2006 Nov 15; 77(5):395-402. PubMed ID: 16879605
    [Abstract] [Full Text] [Related]

  • 6. Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression.
    Bertinetti C, Zirlik K, Heining-Mikesch K, Ihorst G, Dierbach H, Waller CF, Veelken H.
    Cancer Res; 2006 Apr 15; 66(8):4496-502. PubMed ID: 16618777
    [Abstract] [Full Text] [Related]

  • 7. BiovaxID, a personalized therapeutic vaccine against B-cell lymphomas.
    Reinis M.
    Curr Opin Mol Ther; 2008 Oct 15; 10(5):526-34. PubMed ID: 18830928
    [Abstract] [Full Text] [Related]

  • 8. Translational development of vaccination strategies in follicular NHL.
    Sakamaki I, Qin H, Kwak LW.
    Best Pract Res Clin Haematol; 2011 Jun 15; 24(2):295-304. PubMed ID: 21658625
    [Abstract] [Full Text] [Related]

  • 9. Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma.
    Tao MH, Levy R.
    Nature; 1993 Apr 22; 362(6422):755-8. PubMed ID: 8469286
    [Abstract] [Full Text] [Related]

  • 10. Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma.
    Timmerman JM, Vose JM, Czerwinski DK, Weng WK, Ingolia D, Mayo M, Denney DW, Levy R.
    Leuk Lymphoma; 2009 Jan 22; 50(1):37-46. PubMed ID: 19125383
    [Abstract] [Full Text] [Related]

  • 11. Cell-free production of scFv fusion proteins: an efficient approach for personalized lymphoma vaccines.
    Kanter G, Yang J, Voloshin A, Levy S, Swartz JR, Levy R.
    Blood; 2007 Apr 15; 109(8):3393-9. PubMed ID: 17164345
    [Abstract] [Full Text] [Related]

  • 12. BiovaxID idiotype vaccination: active immunotherapy for follicular lymphoma.
    Flowers CR.
    Expert Rev Vaccines; 2007 Jun 15; 6(3):307-17. PubMed ID: 17542746
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic lymphoma vaccines: importance of T-cell immunity.
    Neelapu SS, Lee ST, Qin H, Cha SC, Woo AF, Kwak LW.
    Expert Rev Vaccines; 2006 Jun 15; 5(3):381-94. PubMed ID: 16827622
    [Abstract] [Full Text] [Related]

  • 14. Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response.
    Kwak LW, Young HA, Pennington RW, Weeks SD.
    Proc Natl Acad Sci U S A; 1996 Oct 01; 93(20):10972-7. PubMed ID: 8855293
    [Abstract] [Full Text] [Related]

  • 15. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma.
    Bendandi M, Gocke CD, Kobrin CB, Benko FA, Sternas LA, Pennington R, Watson TM, Reynolds CW, Gause BL, Duffey PL, Jaffe ES, Creekmore SP, Longo DL, Kwak LW.
    Nat Med; 1999 Oct 01; 5(10):1171-7. PubMed ID: 10502821
    [Abstract] [Full Text] [Related]

  • 16. Idiotype vaccination following ABMT can stimulate specific anti-idiotype immune responses in patients with B-cell lymphoma.
    Davis TA, Hsu FJ, Caspar CB, van Beckhoven A, Czerwinsk DK, Liles TM, Taidi B, Benike CJ, Engleman EG, Levy R.
    Biol Blood Marrow Transplant; 2001 Oct 01; 7(9):517-22. PubMed ID: 11669219
    [Abstract] [Full Text] [Related]

  • 17. Phase III randomized study of autologous lymphoma-derived idiotype specific vaccination plus GM-CSF in patients with follicular lymphoma in first complete remission.
    Clin Adv Hematol Oncol; 2003 Jan 01; 1(1):67. PubMed ID: 16227966
    [No Abstract] [Full Text] [Related]

  • 18. Effect of linkage of transduction domain sequences to a lymphoma idiotype DNA vaccine on vaccine effectiveness.
    Ashour AK, Petersen JL, McIlhaney MM, Vose JM, Solheim JC.
    Hybridoma (Larchmt); 2006 Oct 01; 25(5):306-8. PubMed ID: 17044787
    [Abstract] [Full Text] [Related]

  • 19. Prolonged idiotypic vaccination against follicular lymphoma.
    Inoges S, Lopez-Diaz de Cerio A, Zabalegui N, Soria E, Villanueva H, Panizo C, Rodriguez-Caballero A, Suarez L, Pastor F, Rodriguez-Calvillo M, Orfao A, Bendandi M.
    Leuk Lymphoma; 2009 Jan 01; 50(1):47-53. PubMed ID: 19152172
    [Abstract] [Full Text] [Related]

  • 20. Idiotype vaccine strategies for improving outcomes in follicular lymphoma.
    Sinha R, Shenoy PJ, Flowers CR.
    Expert Opin Biol Ther; 2008 Aug 01; 8(8):1213-23. PubMed ID: 18613772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.